Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/25/2025

Troubleshooting Omnipod and Dexcom Communication Loss

Immediate Troubleshooting Steps

  • The American Diabetes Association recommends verifying device proximity, with Dexcom sensors requiring the receiver or smartphone to be within approximately 6 meters for continuous data transmission 1

Common Causes of Communication Loss

  • High-dose acetaminophen (>4g per day), salicylic acid, and ascorbic acid can interfere with Dexcom glucose readings and potentially affect sensor communication, according to the Endocrine Society 3, 2
  • Hypoxemia, severe dehydration, and rapidly changing glucose concentrations can compromise CGM accuracy and connectivity, as stated by the American Association of Clinical Endocrinologists 3

Systematic Troubleshooting Algorithm

  • The American College of Endocrinology suggests confirming Bluetooth is enabled on the smartphone/PDM, checking that the Dexcom app has proper permissions, and ensuring the Omnipod system is properly paired with the Dexcom CGM in the device settings 1, 2, 5

Critical Safety Considerations

  • The FDA recommends always maintaining fingerstick blood glucose monitoring capability as backup, even when using CGM, and using fingerstick testing whenever CGM readings seem inaccurate or during communication loss 6, 2
  • Patients using CGM must have access to blood glucose monitoring at all times, as required by the FDA guidance 6

Preventing Adverse Glycemic Events

  • The American Academy of Family Physicians suggests having rapid-acting insulin available for manual correction doses during system failures, and knowing the signs and symptoms of hypoglycemia and hyperglycemia to recognize problems early 7

Common Pitfalls to Avoid

  • The American Diabetes Association warns not to assume the CGM is accurate during rapid glucose changes (>2 mg/dL/min)—always confirm with fingerstick testing, and never rely solely on CGM data for insulin dosing decisions without confirming accuracy 6, 2

REFERENCES

1

management of diabetes and hyperglycaemia in the hospital. [LINK]

The Lancet Diabetes and Endocrinology, 2021

2

management of diabetes and hyperglycaemia in the hospital. [LINK]

The Lancet Diabetes and Endocrinology, 2021

3

Continuous Glucose Monitoring for Diabetes Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Continuous Glucose Monitoring Systems [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025